High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$15.5M
$15,498,431
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| FLYW |
Flywire Corp
|
10% Owner
Discretionary Buy
|
2026-02-13 | $274,795 | P | Form 4 |
|
PAR
P
PAR TECHNOLOGY CORP
Voss Capital, LP
• 10% Owner
Discretionary Buy
2026-02-04
$1,460,821Largex2
|
||||||
| PAR |
PAR TECHNOLOGY CORP
|
10% Owner
Discretionary Buy
|
2026-02-04 | $1,460,821Largex2 | P | Form 4 |
|
PAR
P
PAR TECHNOLOGY CORP
Voss Capital, LP
• 10% Owner
Discretionary Buy
2026-02-03
$4,188,226Largex4
|
||||||
| PAR |
PAR TECHNOLOGY CORP
|
10% Owner
Discretionary Buy
|
2026-02-03 | $4,188,226Largex4 | P | Form 4 |
| PAR |
PAR TECHNOLOGY CORP
|
10% Owner
Discretionary Buy
|
2026-01-30 | $56,037 | P | Form 4 |
| PAR |
PAR TECHNOLOGY CORP
|
10% Owner
Discretionary Buy
|
2026-01-28 | $1 | P | Form 4 |
|
PAR
P
PAR TECHNOLOGY CORP
Voss Capital, LP
• 10% Owner
Discretionary Buy
2026-01-27
$5,096,376Whalex2
|
||||||
| PAR |
PAR TECHNOLOGY CORP
|
10% Owner
Discretionary Buy
|
2026-01-27 | $5,096,376Whalex2 | P | Form 4 |
| PAR |
PAR TECHNOLOGY CORP
|
10% Owner
Discretionary Buy
|
2026-01-23 | $317,142 | P | Form 4 |
| PAR |
PAR TECHNOLOGY CORP
|
10% Owner
Discretionary Buy
|
2026-01-15 | $1,949,353Large | P | Form 4 |
| PAR |
PAR TECHNOLOGY CORP
|
10% Owner
Discretionary Buy
|
2026-01-14 | $1,604,622Large | P | Form 4 |
|
RNTX
P
Rein Therapeutics, Inc.
Voss Capital, LP
• 10% Owner
Discretionary BuyΔOwn +12.7%
2025-11-14
$127,593
|
||||||
| RNTX |
Rein Therapeutics, Inc.
|
10% Owner
Discretionary BuyΔOwn +12.7%
|
2025-11-14 | $127,593 | P | Form 4 |
|
RNTX
P
Rein Therapeutics, Inc.
Voss Capital, LP
• 10% Owner
Discretionary BuyΔOwn +55.5%
2025-10-28
$247,965
|
||||||
| RNTX |
Rein Therapeutics, Inc.
|
10% Owner
Discretionary BuyΔOwn +55.5%
|
2025-10-28 | $247,965 | P | Form 4 |
|
RNTX
P
Rein Therapeutics, Inc.
Voss Capital, LP
• 10% Owner
Discretionary BuyΔOwn +12.7%
2025-10-27
$133,544x2
|
||||||
| RNTX |
Rein Therapeutics, Inc.
|
10% Owner
Discretionary BuyΔOwn +12.7%
|
2025-10-27 | $133,544x2 | P | Form 4 |
| RNTX |
Rein Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-10-24 | $41,957 | P | Form 4 |